Skip to content
Clinical Trials – home
Research site

Hanusch Krankenhaus

Austria Heinrich-Collin-Straße 30, 1140 Vienna, Austria

  • Hormone receptor positive HER2 negative breast cancer
  • Adult patients

About Specializations

Hanusch Krankenhaus in Vienna, Austria specialises in clinical trials of conditions such as Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on breast cancer. The institution is dedicated to advancing treatment options for patients with node-positive, estrogen receptor-positive, HER2-negative early breast cancer, especially those at a high risk of recurrence.

  • Breast Cancer
  • Endocrine Therapy
  • Invasive Breast Cancer-Free Survival

Through global, multicenter studies, the center evaluates the efficacy of novel therapies such as elacestrant compared to standard endocrine treatments, contributing significantly to the understanding and management of breast cancer.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Heinrich-Collin-Straße 301140 ViennaAustria
Recruiting now
no trials
Conditions studied
1

More sites in ViennaAustria

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

1 clinical trial

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.